IMMUNOMEDICS INC
S-8, EX-23.1, 2001-01-05
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: IMMUNOMEDICS INC, S-8, EX-5.1, 2001-01-05
Next: IMMUNOMEDICS INC, S-8, EX-24.1, 2001-01-05



<PAGE>

                                 Exhibit 23.1

                             ACCOUNTANTS' CONSENT


The Board of Directors
Immunomedics, Inc. :


We consent to the use of our report incorporated herein by reference.


                                                                     KPMG LLP


Short Hills, New Jersey
January 2, 2001


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission